Skip to main content
SpringerLink
Log in

The Cardiomyopathies

  • Chapter
  • First Online:
Echocardiography

  • 2945 Accesses

Abstract

Cardiomyopathies are a diverse group of conditions characterised by structural and functional abnormalities of the heart muscle that are unexplained by coronary artery disease, hypertension or valve disease. They are grouped into morphological and functional phenotypes, each of which can be caused by genetic and non-genetic mechanisms. Most genetic cardiomyopathies are monogenic disorders (i.e. the genetic mutation is sufficient to cause disease), but they can appear sporadic when a mutation has arisen de novo. Non-familial or non-genetic cardiomyopathies are subdivided into idiopathic (no identifiable cause) and acquired disorders in which ventricular dysfunction is a complication of a disorder unrelated to a primary disturbance of cardiomyocyte function. Examples of the latter include cardiac amyloidosis, haemochromatosis and myocarditis. By convention, left ventricular dysfunction caused by coronary artery disease, hypertension, valve disease and congenital heart disease is excluded from the term cardiomyopathy, although they can coexist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270–6.

    Article  Google Scholar 

  2. Elliott RM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 European Society of Cardiology Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J. 2014;35:3733–2779.

    Article  Google Scholar 

  3. Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P, Helio T, Keren A, McKenna WJ, Monserrat L, Pankuweit S, Perrot A, Rapezzi C, Ristic A, Seggewiss H, van LI, Tavazzi L. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2010;31:2715–26.

    Article  Google Scholar 

  4. Nugent AW, Daubeney PE, Chondros P, Carlin JB, Cheung M, Wilkinson LC, Davis AM, Kahler SG, Chow CW, Wilkinson JL, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–46.

    Article  Google Scholar 

  5. Hughes SE, McKenna WJ. New insights into the pathology of inherited cardiomyopathy. Heart. 2005;91:257–64.

    Article  Google Scholar 

  6. Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy – pathology and pathogenesis. Histopathology. 1995;26:493–500.

    Article  CAS  Google Scholar 

  7. Wigle ED, Sasson Z, Henderson MA, Ruddy TD, Fulop J, Rakowski H, Williams WG. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis. 1985;28:1–83.

    Article  CAS  Google Scholar 

  8. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–9.

    Article  Google Scholar 

  9. Rapezzi C, Arbustini E, Caforio AL, Charron P, Gimeno-Blanes J, Heliö T, Linhart A, Mogensen J, Pinto Y, Ristic A, Seggewiss H, Sinagra G, Tavazzi L, Elliott PM. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2013;34(19):1448–58.

    Article  Google Scholar 

  10. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol. 1983;2:437.

    Article  CAS  Google Scholar 

  11. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418–28.

    Article  CAS  Google Scholar 

  12. Nihoyannopoulos P, Karatasakis G, Frenneaux M, McKenna WJ, Oakley CM. Diastolic function in hypertrophic cardiomyopathy; relation to exercise capacity. J Am Coll Cardiol. 1992;19:536–40.

    Article  CAS  Google Scholar 

  13. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, Quinones MA, Roberts R, Marian AJ. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides novel means for an early diagnosis before and independently of hypertrophy. Circulation. 2001;104:128–30.

    Article  CAS  Google Scholar 

  14. Palka P, Lange A, Fleming AD, Donnelly JE, Dutka DP, Starkey IR, Shaw TR, Sutherland GR, Fox KA. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. J Am Coll Cardiol. 1997;30(3):760–8.

    Article  CAS  Google Scholar 

  15. O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM, Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J. 2014;35(30):2010–20.

    Article  Google Scholar 

  16. Guttmann OP, Pavlou M, O’Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM, Hypertrophic Cardiomyopathy Outcomes Investigators. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM risk-CVA). Eur J Heart Fail. 2015;17:837–45.

    Article  Google Scholar 

  17. Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Böhm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016;37(23):1850–8.

    Article  Google Scholar 

  18. McNally EM, Golbus JR, Puckelwartz MJ. Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin Invest. 2013;123(1):19–26.

    Article  CAS  Google Scholar 

  19. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R, Klingel K, Linhart A, Maisch B, McKenna W, Mogensen J, Pinto YM, Ristic A, Schultheiss HP, Seggewiss H, Tavazzi L, Thiene G, Yilmaz A, Charron P, Elliott PM, European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur Heart J. 2013;34(33):2636–48. 2648a-2648d.

    Article  Google Scholar 

  20. Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol. 2000;36:227–32.

    Article  CAS  Google Scholar 

  21. Pinamonti B, Alberti E, Cigalotto A, Dreas L, Salvi A, Silvestri F, Camerini F. Echocardiographic findings in myocarditis. Am J Cardiol. 1988;62:285–91.

    Article  CAS  Google Scholar 

  22. Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. Lancet. 2015;386:813–25.

    Article  Google Scholar 

  23. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. 1997;336:267–76.

    Article  CAS  Google Scholar 

  24. Denfield SW, Rosenthal G, Gajarski RJ, Bricker JT, Schowengerdt KO, Price JK, Towbin JA. Restrictive cardiomyopathies in childhood. Etiologies and natural history. Tex Heart Inst J. 1997;24:38–44.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Mogensen J, Kubo T, Duque M, Uribe W, Shaw A, Murphy R, Gimeno JR, Elliott P, McKenna WJ. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Investig. 2003;111:209–16.

    Article  CAS  Google Scholar 

  26. Shebatai R. Pathophysiology and differential diagnosis of restrictive cardiomyopathy. Cardiovasc Clin. 1988;19:123–32.

    Google Scholar 

  27. Hatle LK, Appleton CP, Popp RL. Differentiation between constrictive pericarditis and restrictive cardiomyopathy by Doppler echocardiography. Circulation. 1989;79:357–70.

    Article  CAS  Google Scholar 

  28. Basso C, Corrado D, Marcus FI, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet. 2009;373(9671):1289–300.

    Article  Google Scholar 

  29. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Eur Heart J. 2010;31(7):806–14.

    Article  Google Scholar 

  30. Foale RA, Nihoyannopoulos P, McKenna WJ, Kleinebenne A, Nadazdin A, Rowland E, Smith G. The echocardiographic measurements of the normal adult right ventricle. Br Heart J. 1986;56:33.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Imperial College London, Hammersmith Hospital, London, UK

    Petros Nihoyannopoulos

  2. University College London, London, UK

    Perry Elliott

  3. UCL Institute of Cardiovascular Science, London, UK

    Perry Elliott

  4. Barts Heart Centre, St. Bartholomew’s Hospital, London, UK

    Perry Elliott

Authors
  1. Petros Nihoyannopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Perry Elliott
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Petros Nihoyannopoulos .

Editor information

Editors and Affiliations

  1. Hammersmith Hospital, Imperial College London National Heart & Lung Institute, London, UK

    Petros Nihoyannopoulos

  2. Duke Heart Center, Duke University Medical Center, Durham, NC, USA

    Joseph Kisslo

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nihoyannopoulos, P., Elliott, P. (2018). The Cardiomyopathies. In: Nihoyannopoulos, P., Kisslo, J. (eds) Echocardiography. Springer, Cham. https://doi.org/10.1007/978-3-319-71617-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-71617-6_24

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-71615-2

  • Online ISBN: 978-3-319-71617-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation